Claire Hamela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claire Hamela has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Laurent Kremer
Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier
4 shared publications Albert Yick Hou Lim
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Department for Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore
1 shared publication- Alexander Krah
Korea Institute for Advanced Study, School of Computational Sciences, Seoul, South Korea
1 shared publication - Andréanne Lupien
École Polytechnique Fédérale de Lausanne
1 shared publication - Carmen Jia Ern Pee
Nanyang Technological University
1 shared publication - Christian Chalut
Univ Toulouse
1 shared publication
Latest Publications
- Open Access
- 8 April 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111433
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus
- 8 April 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (6) , 111433
Open AccessPharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus
- Open Access
- 11 December 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (12) , e0297024
Trehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis
Mycobacteria produce a large repertoire of surface-exposed lipids with major biological functions. Among these lipids, trehalose polyphleates (TPPs) are instrumental in the infection of Mycobacterium abscessus by the therapeutic phage BPs. However, while the biosynthesis and transport of TPPs across the membrane by MmpL10 have been reported, the role of TPPs in host infection remains enigmatic. Here, we addressed whether the loss of TPPs influences interactions with macrophages and the virulence of M. abscessus . As anticipated, the deletion of mmpL10 in smooth (S) and rough (R) variants of M. abscessus abrogated TPP production, which was rescued upon gene complementation. Importantly, infection of human THP-1 cells with the mmpL10 mutants was associated with decreased intramacrophage survival and a reduced proportion of infected cells. The rough mmpL10 mutant showed an impaired capacity to block phagosomal acidification and was unable to co-localize with Galectin-3, a marker of phagosomal membrane damage. This suggests that TPPs participate, directly or indirectly, in phagolysosomal fusion and in phagosomal membrane damage to establish cytosolic communication. The TPP defect that affects the fitness and virulence of M. abscessus was further demonstrated in zebrafish embryos using a rough clinical strain resistant to phage BPs and harboring a frameshift mutation in mmpL10 . Infection with this strain was correlated with a slight decrease in embryo survival and a reduced bacterial burden as compared to the corresponding parental and complemented derivatives. Together, these results indicate that TPPs are important surface lipids contributing to the pathogenicity of M. abscessus . IMPORTANCE: Trehalose polyphleates (TPPs) are complex lipids associated with the mycobacterial cell surface and were identified 50 years ago. While the TPP biosynthetic pathway has been described recently, the role of these lipids in the biology of mycobacteria remains yet to be established. The wide distribution of TPPs across mycobacterial species suggests that they may exhibit important functions in these actinobacteria. Here, we demonstrate that Mycobacterium abscessus, an emerging multidrug-resistant pathogen that causes severe lung diseases in cystic fibrosis patients, requires TPPs for survival in macrophages and virulence in a zebrafish model of infection. These findings support the importance of this underexplored family of lipids in mycobacterial pathogenesis.
- 11 December 2024
- Published by American Society for Microbiology in mBio
- Vol. 15 (12) , e0297024
Open AccessTrehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis
Mycobacteria produce a large repertoire of surface-exposed lipids with major biological functions. Among these lipids, trehalose polyphleates (TPPs) are instrumental in the infection of Mycobacterium abscessus by the therapeutic phage BPs. However, while the biosynthesis and transport of TPPs across the membrane by MmpL10 have been reported, the role of TPPs in host infection remains enigmatic. Here, we addressed whether the loss of TPPs influences interactions with macrophages and the virulence of M. abscessus . As anticipated, the deletion of mmpL10 in smooth (S) and rough (R) variants of M. abscessus abrogated TPP production, which was rescued upon gene complementation. Importantly, infection of human THP-1 cells with the mmpL10 mutants was associated with decreased intramacrophage survival and a reduced proportion of infected cells. The rough mmpL10 mutant showed an impaired capacity to block phagosomal acidification and was unable to co-localize with Galectin-3, a marker of phagosomal membrane damage. This suggests that TPPs participate, directly or indirectly, in phagolysosomal fusion and in phagosomal membrane damage to establish cytosolic communication. The TPP defect that affects the fitness and virulence of M. abscessus was further demonstrated in zebrafish embryos using a rough clinical strain resistant to phage BPs and harboring a frameshift mutation in mmpL10 . Infection with this strain was correlated with a slight decrease in embryo survival and a reduced bacterial burden as compared to the corresponding parental and complemented derivatives. Together, these results indicate that TPPs are important surface lipids contributing to the pathogenicity of M. abscessus . IMPORTANCE: Trehalose polyphleates (TPPs) are complex lipids associated with the mycobacterial cell surface and were identified 50 years ago. While the TPP biosynthetic pathway has been described recently, the role of these lipids in the biology of mycobacteria remains yet to be established. The wide distribution of TPPs across mycobacterial species suggests that they may exhibit important functions in these actinobacteria. Here, we demonstrate that Mycobacterium abscessus, an emerging multidrug-resistant pathogen that causes severe lung diseases in cystic fibrosis patients, requires TPPs for survival in macrophages and virulence in a zebrafish model of infection. These findings support the importance of this underexplored family of lipids in mycobacterial pathogenesis.
- Open Access
- 3 January 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (2) , 105618
High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivo
- 3 January 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (2) , 105618
Open AccessHigh efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivo
- Open Access
- 12 October 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (10) , e1009965
Efficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
Mycobacterium abscessusis the most common rapidly growing non-tuberculous mycobacteria to cause pulmonary disease in patients with impaired lung function such as cystic fibrosis.M.abscessusdisplays high intrinsic resistance to common antibiotics and inducible resistance to macrolides like clarithromycin. As such,M.abscessusis clinically resistant to the entire regimen of front-lineM.tuberculosisdrugs, and treatment with antibiotics that do inhibitM.abscessusin the lab results in cure rates of 50% or less. Here, we identified epetraborole (EPT) from the MMV pandemic response box as an inhibitor against the essential protein leucyl-tRNA synthetase (LeuRS) inM.abscessus. EPT protected zebrafish from lethalM.abscessusinfection and did not induce self-resistance nor against clarithromycin. Contrary to most antimycobacterials, the whole-cell activity of EPT was greater againstM.abscessusthanM.tuberculosis, but crystallographic and equilibrium binding data showed that EPT binds LeuRSMabsand LeuRSMtbwith similar residues and dissociation constants. Since EPT-resistantM.abscessusmutants lost LeuRS editing activity, these mutants became susceptible to misaminoacylation with leucine mimics like the non-proteinogenic amino acid norvaline. Proteomic analysis revealed that whenM.abscessusLeuRS mutants were fed norvaline, leucine residues in proteins were replaced by norvaline, inducing the unfolded protein response with temporal changes in expression of GroEL chaperonins and Clp proteases. This supports ourin vitrodata that supplementation of media with norvaline reduced the emergence of EPT mutants in bothM.abscessusandM.tuberculosis. Furthermore, the combination of EPT and norvaline had improvedin vivoefficacy compared to EPT in a murine model ofM.abscessusinfection. Our results emphasize the effectiveness of EPT against the clinically relevant cystic fibrosis pathogenM.abscessus, and these findings also suggest norvaline adjunct therapy with EPT could be beneficial forM.abscessusand other mycobacterial infections like tuberculosis.
- 12 October 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (10) , e1009965
Open AccessEfficacy of epetraborole against Mycobacterium abscessus is increased with norvaline
Mycobacterium abscessusis the most common rapidly growing non-tuberculous mycobacteria to cause pulmonary disease in patients with impaired lung function such as cystic fibrosis.M.abscessusdisplays high intrinsic resistance to common antibiotics and inducible resistance to macrolides like clarithromycin. As such,M.abscessusis clinically resistant to the entire regimen of front-lineM.tuberculosisdrugs, and treatment with antibiotics that do inhibitM.abscessusin the lab results in cure rates of 50% or less. Here, we identified epetraborole (EPT) from the MMV pandemic response box as an inhibitor against the essential protein leucyl-tRNA synthetase (LeuRS) inM.abscessus. EPT protected zebrafish from lethalM.abscessusinfection and did not induce self-resistance nor against clarithromycin. Contrary to most antimycobacterials, the whole-cell activity of EPT was greater againstM.abscessusthanM.tuberculosis, but crystallographic and equilibrium binding data showed that EPT binds LeuRSMabsand LeuRSMtbwith similar residues and dissociation constants. Since EPT-resistantM.abscessusmutants lost LeuRS editing activity, these mutants became susceptible to misaminoacylation with leucine mimics like the non-proteinogenic amino acid norvaline. Proteomic analysis revealed that whenM.abscessusLeuRS mutants were fed norvaline, leucine residues in proteins were replaced by norvaline, inducing the unfolded protein response with temporal changes in expression of GroEL chaperonins and Clp proteases. This supports ourin vitrodata that supplementation of media with norvaline reduced the emergence of EPT mutants in bothM.abscessusandM.tuberculosis. Furthermore, the combination of EPT and norvaline had improvedin vivoefficacy compared to EPT in a murine model ofM.abscessusinfection. Our results emphasize the effectiveness of EPT against the clinically relevant cystic fibrosis pathogenM.abscessus, and these findings also suggest norvaline adjunct therapy with EPT could be beneficial forM.abscessusand other mycobacterial infections like tuberculosis.